"Investing Amid Low Expected Returns” de Antti Ilmanen
Noticias empresas
-
-
How The Investment Story For Shell (LSE:SHEL) Is Shifting As Analyst Views Split - Shell’s updated fair value estimate has shifted from £34.65 to £37.17, giving you a fresh reference point for how analysts are framing the shares today. Be...Hace 7 horas
-
I’m 72: Here’s the Exact Script I Used To Cut My Cellphone Bill by $312 Annually - Robert T., 72, cut his cellphone bill by $26/month ($312/year) using this exact negotiation script. Here's what he said to Verizon.Hace 10 horas
-
Where Will Pfizer Stock Be in 3 Years? - The healthcare giant has been investing heavily in its future growth.Hace 15 horas
-
A Dividend Portfolio That Pays Double the U.S. Median Household Income - The U.S. median household income runs about $80,000 per year. Double that, and you arrive at $160,000, a figure that represents genuine financial comfort i...Hace 18 horas
-
A Dividend Portfolio That Pays Double the U.S. Median Household Income - The U.S. median household income runs about $80,000 per year. Double that, and you arrive at $160,000, a figure that represents genuine financial comfort i...Hace 18 horas
-
Four High-Yield Stocks That Could Fund Your $60,000 Annual Retirement Income - Four tickers. One goal: $60,000 a year in income without touching a paycheck. The question is how much capital it takes to get there, and what you give up ...Hace 19 horas
-
Texas Instruments (TXN) Stock Is Up, What You Need To Know - Shares of analog chip manufacturer Texas Instruments (NASDAQ:TXN) jumped 2.7% in the afternoon session after the US-Iran ceasefire eased fears of a major d...Hace 1 día
-
3M Is Running 3.6% Higher Ahead of Earnings. Has This Former Dividend King Reignited Its Growth Story? - 3M (NYSE: MMM) reports Q1 2026 earnings on April 21 before the market opens. After losing its Dividend King status in 2024 and navigating a volatile start ...Hace 1 día
-
Will Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings? - MIRM heads into Q1 earnings with Livmarli sales in focus after 69% year-over-year growth in 2025. Bile acid products broaden revenue momentum.Hace 1 día
No hay comentarios:
Publicar un comentario